ArticleInternational journal of pharmaceutics: X2025

Liposomal glytrexate formulation: improving antitumour efficacy and minimizing toxicity in breast cancer therapy.

Wenli He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.